Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Y Ku

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Journal of Gastrointestinal Oncology|July 12, 2023
Perioperative versus total neoadjuvant chemotherapy in gastric cancerJessica Yang, Megan Greally, Vivian E Strong, et al.
International Journal of Cancer|December 27, 2022
Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomyThomas Boerner, Rebecca A Carr, Meier Hsu, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 15, 2018
Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC ExperienceTamar B Nobel, Arianna Barbetta, Meier Hsu, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinomaGeoffrey Y Ku, Manjit S Bains, Do Joong Park, et al.
Annals of Surgical Oncology|August 12, 2015
Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric AdenocarcinomaDo Joong Park, An Na Seo, Changhwan Yoon, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2022
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinomaRyan H Moy, Megan Greally, Joanne F Chou, et al.
Annals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.
Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Journal of Gastrointestinal Oncology|July 12, 2023
Perioperative versus total neoadjuvant chemotherapy in gastric cancerJessica Yang, Megan Greally, Vivian E Strong, et al.
International Journal of Cancer|December 27, 2022
Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomyThomas Boerner, Rebecca A Carr, Meier Hsu, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 15, 2018
Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC ExperienceTamar B Nobel, Arianna Barbetta, Meier Hsu, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinomaGeoffrey Y Ku, Manjit S Bains, Do Joong Park, et al.
Annals of Surgical Oncology|August 12, 2015
Serum VEGF-A and Tumor Vessel VEGFR-2 Levels Predict Survival in Caucasian but Not Asian Patients Undergoing Resection for Gastric AdenocarcinomaDo Joong Park, An Na Seo, Changhwan Yoon, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2022
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinomaRyan H Moy, Megan Greally, Joanne F Chou, et al.
Annals of Surgical Oncology|February 10, 2021
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of RecurrenceMasaya Nakauchi, Elvira Vos, Laura H Tang, et al.
Annals of Surgical Oncology|April 8, 2021
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer ResectionMasaya Nakauchi, Elvira L Vos, Laura H Tang, et al.
Cytotherapy|November 12, 2009
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responsesYun Lin, Humilidad F Gallardo, Geoffrey Y Ku, et al.
Pageof 11